SALARIUS PHARMACEUTICALS INC (SLRX) Stock Balance Sheet
USA - NASDAQ:SLRX - US79400X5032 - Common Stock
3.85 USD
-0.04 (-1.03%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 794.90K | 2.44M | 5.90M | 12.11M | 29.21M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | N/A | N/A | 0.00 | 1.61M | 0.00 | |||
| Inventories | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 564.70K | 553.00K | 620.00K | 803.00K | 949.00K | |||
| Total Current Assets | 1.36M | 2.99M | 6.52M | 14.52M | 30.16M | |||
| Non-Current Assets | ||||||||
| PPE Net | N/A | N/A | N/A | N/A | 8.00K | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Goodwill | N/A | N/A | N/A | 0.00 | 8.87M | |||
| Other Non-Current Assets | 33.20K | 35.00K | 67.00K | 131.00K | 186.00K | |||
| Total Non-Current Assets | 33.20K | 35.00K | 67.00K | 131.00K | 10.67M | |||
| TOTAL ASSETS | 1.39M | 3.02M | 6.59M | 14.65M | 40.83M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 222.00K | 290.00K | 0.00 | 0.00 | |||
| Accrued Expenses | 740.60K | 352.00K | 407.00K | 1.41M | 553.00K | |||
| Accounts Payable | 1.48M | 937.00K | 603.00K | 2.86M | 1.54M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | 15.00K | |||
| Total Current Liabilities | 2.22M | 1.51M | 1.30M | 4.27M | 2.11M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 2.22M | 1.51M | 1.30M | 4.27M | 2.11M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -84.59M | -81.92M | -76.35M | -63.80M | -32.20M | |||
| Additional Paid In Capital | 83.76M | 83.44M | 81.64M | 74.19M | 70.92M | |||
| Common Shares | 200.00 | 0.00 | 0.00 | 0.00 | 5.00K | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 141.80K | 96.10K | 32.80K | 18.80K | 15.10K | |||
| Tangible Book Value per Share | -5.85 | 1.05 | 10.75 | 36.83 | 1.98K | |||
| Total Shareholders' Equity | -829.70K | 1.51M | 5.29M | 10.38M | 38.72M | |||
| TOTAL LIABILITIES AND EQUITY | 1.39M | 3.02M | 6.59M | 14.65M | 40.83M | |||
| Statistics | ||||||||
| Current Ratio | 0.61 | 1.98 | 5.02 | 3.40 | 14.29 | |||
| Return On Assets (ROA) | -366.41% | -184.45% | -190.42% | -215.74% | -31.27% | |||
| Return On Equity (ROE) | N/A | -368.77% | -237.24% | -304.36% | -32.97% | |||
All data in USD , ROIC based on taxRate of 0.21